Remove Filler Remove Protein Remove Trials
article thumbnail

Bone Void Filler Cerament G: The Combination Product by BONESUPPORT Gets Market Authorization from the FDA

XTalks

Ceramanet G, a bone void filler with the antibiotic gentamicin, fills bone voids and immediately begins bone healing with protection. Cerament G is a bone void filler treatment that can fill the gaps in the affected bones and simultaneously deliver the antibiotic gentamicin to reduce the risk of reinfection. mg/mL of cerament paste.

Filler 98
article thumbnail

TLC Announces Full Patient Enrollment in EXCELLENCE Trial of TLC599 for Osteoarthritis PainOn-schedule completion of enrollment despite COVID-19 pandemic; unique trial design evaluates safety and efficacy of single & repeat doses

The Pharma Data

In these unprecedented times, we are especially grateful for the dedication of our research site staff and trial participants, whose commitment to EXCELLENCE facilitated the advancement of our lead program,” said George Yeh, President of TLC. “We SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Dec.

Trials 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CarboFix

The Pharma Data

It’s all based on human biology… I refer to it as your “metabolism switch”… But the scientific name for it is AMP-activated protein kinase…. …so you can see that there are no fillers…. How little you exercise…. It’s the genetic master switch that controls our metabolism.

article thumbnail

Emotional empathy is driving brand equity

pharmaphorum

We see the dedication of healthcare workers – or of the shelf-filler in our local store – and we are moved to thank them and to make our own contribution. They’re also investing heavily in trials of the best candidates. Although not yet approved as a treatment for coronavirus, Kaletra has shown efficacy across multiple trial cases.

Branding 112